1. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N Engl J Med,2013
2. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma;Neelapu;N Engl J Med,2017
3. Chimeric antigen receptor-t cells for targeting solid tumors: current challenges and existing strategies;Springuel;BioDrugs Clin Immunother Biopharm Gene Ther,2019
4. Rousseau A, Gougis P. Les CAR-T cells à l’épreuve de l’oncologie solide. Innov Thérapeutiques En Oncol [Internet]. 1 nov 2015 [cité 10 oct 2020];1(1). Disponible sur: http://www.jle.com/fr/revues/ito/e-docs/les_car_t_cells_a_lepreuve_de_loncologie_solide_318620/article.phtml?tab=texte.
5. CAR T cell therapies for patients with multiple myeloma;Mikkilineni;Nat Rev Clin Oncol,2021